{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:41:30Z","timestamp":1794328890573,"version":"4.9.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10072-026-09274-z","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T01:44:58Z","timestamp":1785462298000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and safety of fecal microbiota transplantation in Parkinson\u2019s disease: a systematic review and meta-analysis of randomized controlled trials with GRADE assessment"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8616-6644","authenticated-orcid":false,"given":"Aya Magdy","family":"Siam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6178-8183","authenticated-orcid":false,"given":"Elsayed S.","family":"Moubarak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4127-2612","authenticated-orcid":false,"given":"Nour-Eldin","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4672-2410","authenticated-orcid":false,"given":"Hamza","family":"Khelifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Aljalawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4341-7330","authenticated-orcid":false,"given":"Abdelrahman A.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7736-9660","authenticated-orcid":false,"given":"Nour Aldin T.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0891-3561","authenticated-orcid":false,"given":"Mohamed","family":"Wagdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1094-6382","authenticated-orcid":false,"given":"Youssef","family":"Heikal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar Fayez","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"9274_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2025.07.003","volume":"581","author":"S Yadav","year":"2025","unstructured":"Yadav S, Raj RG (2025) Parkinson\u2019s disease and the gut microbiota connection: unveiling dysbiosis and exploring therapeutic horizons. Neuroscience 581:1\u201315","journal-title":"Neuroscience"},{"key":"9274_CR2","doi-asserted-by":"crossref","unstructured":"Figura M, Milanowski \u0141, Nowak JM, Antoniak A, Kopczy\u0144ski M, Zaj\u0105c W et al (2026) Safety and Efficacy of Fecal Microbiota Transplantation in Alleviating Symptoms of Parkinson\u2019s Disease: A Randomized, Placebo-Controlled, Double-Blinded Study. Ann Neurol","DOI":"10.1002\/ana.78153"},{"key":"9274_CR3","doi-asserted-by":"crossref","unstructured":"Gabrielli M, Zileri Dal Verme L, Zocco MA, Nista EC, Ojetti V, Gasbarrini A (2024) The role of the gastrointestinal microbiota in parkinson\u2019s disease. Biomolecules 15(1):6","DOI":"10.3390\/biom15010026"},{"key":"9274_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2017.02.002","volume":"38","author":"A Parashar","year":"2017","unstructured":"Parashar A, Udayabanu M (2017) Gut microbiota: Implications in Parkinson\u2019s disease. Parkinsonism Relat Disord 38:1\u20137","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"9274_CR5","doi-asserted-by":"publisher","first-page":"e268","DOI":"10.1002\/mco2.268","volume":"4","author":"Z Jiang","year":"2023","unstructured":"Jiang Z, Wang X, Zhang H, Yin J, Zhao P, Yin Q et al (2023) Ketogenic diet protects MPTP-induced mouse model of Parkinson\u2019s disease via altering gut microbiota and metabolites. MedComm 4(3):e268","journal-title":"MedComm"},{"issue":"4","key":"9274_CR6","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1007\/s13311-020-00942-2","volume":"17","author":"EG Brown","year":"2020","unstructured":"Brown EG, Goldman SM (2020) Modulation of the microbiome in parkinson\u2019s disease: diet, drug, stool transplant, and beyond. Neurotherapeutics 17(4):1406\u20131417","journal-title":"Neurotherapeutics"},{"key":"9274_CR7","doi-asserted-by":"crossref","unstructured":"Munteanu C, Onose G, Rotariu M, Po\u0219taru M, Turnea M, Galaction AI (2024) Role of Microbiota-Derived Hydrogen Sulfide (H2S) in Modulating the Gut-Brain Axis: Implications for Alzheimer\u2019s and Parkinson\u2019s Disease Pathogenesis. Biomedicines 12(12):2670","DOI":"10.3390\/biomedicines12122670"},{"issue":"6","key":"9274_CR8","doi-asserted-by":"publisher","first-page":"e00462","DOI":"10.1016\/j.neurot.2024.e00462","volume":"21","author":"AM Hamilton","year":"2024","unstructured":"Hamilton AM, Krout IN, White AC, Sampson TR (2024) Microbiome-based therapeutics for Parkinson\u2019s disease. Neurotherapeutics 21(6):e00462","journal-title":"Neurotherapeutics"},{"issue":"1","key":"9274_CR9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s40168-021-01107-9","volume":"9","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Ning J, Bao X-Q, Shang M, Ma J, Li G et al (2021) Fecal microbiota transplantation protects rotenone-induced Parkinson\u2019s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome 9(1):226","journal-title":"Microbiome"},{"key":"9274_CR10","doi-asserted-by":"publisher","first-page":"1104759","DOI":"10.3389\/fneur.2023.1104759","volume":"14","author":"HL DuPont","year":"2023","unstructured":"DuPont HL, Suescun J, Jiang Z-D, Brown EL, Essigmann HT, Alexander AS et al (2023) Fecal microbiota transplantation in Parkinson\u2019s disease-A randomized repeat-dose, placebo-controlled clinical pilot study. Front Neurol 14:1104759","journal-title":"Front Neurol"},{"key":"9274_CR11","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372","DOI":"10.1136\/bmj.n71"},{"key":"9274_CR12","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions | Cochrane [Internet]. [cited 2026 Jan 1]. Available from: http:\/\/www.training.cochrane.org\/handbook"},{"issue":"1","key":"9274_CR13","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan-a web and mobile app for systematic reviews. Syst Rev 5(1):210","journal-title":"Syst Rev"},{"key":"9274_CR14","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898","journal-title":"BMJ"},{"key":"9274_CR15","unstructured":"GRADE | Cochrane [Internet] [cited 2026 Jan 29]. Available from: https:\/\/www.cochrane.org\/learn\/courses-and-resources\/cochrane-methodology\/grade"},{"issue":"2","key":"9274_CR16","doi-asserted-by":"publisher","first-page":"2284247","DOI":"10.1080\/19490976.2023.2284247","volume":"15","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, Tan G, Zhu Q, Wang C, Ruan G, Ying S et al (2023) Efficacy of fecal microbiota transplantation in patients with Parkinson\u2019s disease: clinical trial results from a randomized, placebo-controlled design. Gut Microbes 15(2):2284247","journal-title":"Gut Microbes"},{"key":"9274_CR17","doi-asserted-by":"publisher","first-page":"102563","DOI":"10.1016\/j.eclinm.2024.102563","volume":"71","author":"A Bruggeman","year":"2024","unstructured":"Bruggeman A, Vandendriessche C, Hamerlinck H, De Looze D, Tate DJ, Vuylsteke M et al (2024) Safety and efficacy of faecal microbiota transplantation in patients with mild to moderate Parkinson\u2019s disease (GUT-PARFECT): a double-blind, placebo-controlled, randomised, phase 2 trial. EClinicalMedicine 71:102563","journal-title":"EClinicalMedicine"},{"issue":"9","key":"9274_CR18","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1001\/jamaneurol.2024.2305","volume":"81","author":"F Scheperjans","year":"2024","unstructured":"Scheperjans F, Levo R, Bosch B, L\u00e4\u00e4peri M, Pereira PAB, Smolander O-P et al (2024) Fecal microbiota transplantation for treatment of parkinson disease: A randomized clinical trial. JAMA Neurol 81(9):925\u2013938","journal-title":"JAMA Neurol"},{"key":"9274_CR19","doi-asserted-by":"publisher","first-page":"106086","DOI":"10.1016\/j.bbi.2025.106086","volume":"130","author":"J Wang","year":"2025","unstructured":"Wang J, Xue L, Zhang M, Shen P, Zhao W, Tong Q et al (2025) Colonoscopic fecal microbiota transplantation for Mild-to-Moderate Parkinson\u2019s Disease: A randomized controlled trial. Brain Behav Immun 130:106086","journal-title":"Brain Behav Immun"},{"key":"9274_CR20","doi-asserted-by":"crossref","unstructured":"Zhang R, Feng R, Wang J, Chen Y, Liu H, Zhu Q et al (2026) Gut microbiota modulation via repeated donor fecal transplantation improves motor and gastrointestinal symptoms in drug-na\u00efve Parkinson\u2019s disease: a randomized phase 2 trial. Signal Transduct Target Ther. ;11(1)","DOI":"10.1038\/s41392-026-02604-9"},{"issue":"5532","key":"9274_CR21","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1126\/science.1060937","volume":"293","author":"R de la Fuente-Fern\u00e1ndez","year":"2001","unstructured":"de la Fuente-Fern\u00e1ndez R, Ruth TJ, Sossi V, Schulzer M, Calne DB, Stoessl AJ (2001) Expectation and dopamine release: mechanism of the placebo effect in Parkinson\u2019s disease. Science 293(5532):1164\u20131166","journal-title":"Science"},{"key":"9274_CR22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/bs.irn.2020.03.031","volume":"153","author":"J-S Lou","year":"2020","unstructured":"Lou J-S (2020) Placebo responses in Parkinson\u2019s disease. Int Rev Neurobiol 153:187\u2013211","journal-title":"Int Rev Neurobiol"},{"issue":"2","key":"9274_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RAI, Jansen Steur ENH, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24(2):197\u2013211","journal-title":"Neurobiol Aging"},{"issue":"4","key":"9274_CR24","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon S-H, Kam T-I, Panicker N, Karuppagounder SS, Lee S et al (2019) Transneuronal Propagation of Pathologic \u03b1-Synuclein from the Gut to the Brain Models Parkinson\u2019s Disease. Neuron 103(4):627\u2013641e7","journal-title":"Neuron"},{"issue":"3","key":"9274_CR25","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","volume":"30","author":"F Scheperjans","year":"2015","unstructured":"Scheperjans F, Aho V, Pereira PAB, Koskinen K, Paulin L, Pekkonen E et al (2015) Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype. Mov Disord 30(3):350\u2013358","journal-title":"Mov Disord"},{"issue":"12","key":"9274_CR26","doi-asserted-by":"publisher","first-page":"e28032","DOI":"10.1371\/journal.pone.0028032","volume":"6","author":"CB Forsyth","year":"2011","unstructured":"Forsyth CB, Shannon KM, Kordower JH, Voigt RM, Shaikh M, Jaglin JA et al (2011) Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease. PLoS ONE 6(12):e28032","journal-title":"PLoS ONE"},{"issue":"6","key":"9274_CR27","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE et al (2016) Gut microbiota regulate motor deficits and neuroinflammation in a model of parkinson\u2019s disease. Cell 167(6):1469\u20131480e12","journal-title":"Cell"},{"issue":"4","key":"9274_CR28","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","volume":"99","author":"JF Cryan","year":"2019","unstructured":"Cryan JF, O\u2019Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M et al (2019) The Microbiota-Gut-Brain Axis. Physiol Rev 99(4):1877\u20132013","journal-title":"Physiol Rev"},{"issue":"11","key":"9274_CR29","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V (2022) Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol 22(11):657\u2013673","journal-title":"Nat Rev Immunol"},{"issue":"6445","key":"9274_CR30","doi-asserted-by":"publisher","first-page":"eaau6323","DOI":"10.1126\/science.aau6323","volume":"364","author":"V Maini Rekdal","year":"2019","unstructured":"Maini Rekdal V, Bess EN, Bisanz JE, Turnbaugh PJ, Balskus EP (2019) Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism. Science 364(6445):eaau6323","journal-title":"Science"},{"issue":"21","key":"9274_CR31","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","volume":"381","author":"Z DeFilipp","year":"2019","unstructured":"DeFilipp Z, Bloom PP, Torres Soto M, Mansour MK, Sater MRA, Huntley MH et al (2019) Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant. N Engl J Med 381(21):2043\u20132050","journal-title":"N Engl J Med"},{"issue":"5","key":"9274_CR32","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1205037","volume":"368","author":"E van Nood","year":"2013","unstructured":"van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM et al (2013) Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 368(5):407\u2013415","journal-title":"N Engl J Med"},{"key":"9274_CR33","doi-asserted-by":"publisher","first-page":"1639911","DOI":"10.3389\/fnins.2025.1639911","volume":"19","author":"K Chen","year":"2025","unstructured":"Chen K, Sun L, Liu Y, Chen R (2025) Safety and efficacy of fecal microbiota transplantation in the treatment of Parkinson\u2019s disease: a systematic review of clinical trials. Front Neurosci 19:1639911","journal-title":"Front Neurosci"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09274-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09274-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09274-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:40:24Z","timestamp":1786588824000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-09274-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["9274"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09274-z","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"28 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no relevant competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"<b>Consent for publication<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"668"}}